Corcept Therapeutics Inc CORT
2 targets with a reported result
Releases of the last 3 yearsThe numbers CORT said it expected, in its earnings releases, next to what it then reported for the same period.
Target by target
Each target, with the sentence it came from · release and 10-Q or 10-K
| Target | What the company said | Reported | Result | |
|---|---|---|---|---|
| Revenue Fiscal 2026 |
Given $900.00M to $1.00B release Feb 24, 2026
Raised $950.00M to $1.05B release Apr 30, 2026
Raised $1.10B to $1.20B release Jul 29, 2026
Kept $1.10B to $1.20B release Nov 3, 2026
|
– | Not reported yet | |
The company's wordsFull year 2026 revenue guidance of $900 – $1,000 million release Feb 24, 2026 We have increased our 2026 revenue guidance to $950 – $1,050 million,” said Joseph K. Belanoff, M.D., Corcept’s Chief Executive Officer. release Apr 30, 2026 We anticipate continued strength across our businesses and have increased our 2026 revenue guidance to $1.1 – $1.2 billion,” said Joseph K. Belanoff, M.D., Corcept’s Chief Executive Officer. release Jul 29, 2026 Reiterated 2026 revenue guidance of $1.1 – $1.2 billion release Nov 3, 2026 | ||||
| Revenue Fiscal 2025 (ended Dec 31, 2025) |
Given $900.00M to $950.00M release Feb 26, 2025
Kept $900.00M to $950.00M release May 5, 2025
Lowered $850.00M to $900.00M release Jul 31, 2025
Lowered $800.00M to $850.00M release Nov 4, 2025
|
$761.41M 10-K filed 2026-02-24 |
Below the range | |
The company's words2025 revenue guidance of $900 – $950 million release Feb 26, 2025 Reiterated 2025 revenue guidance of $900 – $950 million release May 5, 2025 Modified 2025 revenue guidance of $850 – $900 million release Jul 31, 2025 Modified 2025 revenue guidance of $800 – $850 million release Nov 4, 2025 | ||||
| Revenue Fiscal 2024 (ended Dec 31, 2024) |
Given $600.00M to $630.00M release Jan 8, 2024
Kept $600.00M to $630.00M release Feb 15, 2024
Raised $620.00M to $650.00M release May 1, 2024
Raised $640.00M to $670.00M release Jul 29, 2024
Raised $675.00M to $700.00M release Oct 30, 2024
|
$675.04M 10-K filed 2025-02-26 |
Within the range | |
The company's words2024 revenue guidance of $600 – $630 million release Jan 8, 2024 Reiterated 2024 revenue guidance of $600 – $630 million release Feb 15, 2024 The company increased its 2024 revenue guidance to $620 – $650 million . release May 1, 2024 The company increased its 2024 revenue guidance to $640 – $670 million. release Jul 29, 2024 The company increased its 2024 revenue guidance to $675 – $700 million. release Oct 30, 2024 | ||||
Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (13 releases since 2024-01-08), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.
Sources
The outlook sentences of each earnings release (8-K item 2.02, exhibit 99), read without AI; results from SEC's XBRL company facts, as first reported.
Also
Earnings releases: each release in full.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/CORT/export.csv") into a cell.